tiprankstipranks
Trending News
More News >
GlobeImmune (GBIM)
OTHER OTC:GBIM
US Market

GlobeImmune (GBIM) Financial Statements

Compare
23 Followers

GlobeImmune Financial Overview

GlobeImmune's market cap is currently $575.00. The company's EPS TTM is $; its P/E ratio is ―; GlobeImmune is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19
Currency in USD

GlobeImmune Earnings and Revenue History

GlobeImmune Debt to Assets

GlobeImmune Cash Flow

GlobeImmune Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.